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Introduction {#sec001}
============

Acne vulgaris is a common chronic skin disease characterized by comedones, papules, and pustules and is associated with negative sequelae including scarring and pigmentation, which causes a high degree of psychosocial suffering \[[@pone.0120171.ref001]--[@pone.0120171.ref003]\]. It affects about 85% of individuals between the ages of 12 to 24 years \[[@pone.0120171.ref004],[@pone.0120171.ref005]\]. Topical antibiotics, keratolytics, and retinoids are the main first-line treatment options for comedogenic and mild inflammatory acne. Combination therapy is often used in many clinical settings in order to target different pathogenic factors \[[@pone.0120171.ref004],[@pone.0120171.ref006]--[@pone.0120171.ref008]\].

Adapalene, (6-\[3-(1-adamantyl)-4-methoxyphenyl\]-2- naphthoic acid) ([Fig. 1](#pone.0120171.g001){ref-type="fig"}) is a synthetic naphthoic acid derivative, third-generation retinoid with slightly better efficacy and light stability \[[@pone.0120171.ref009],[@pone.0120171.ref010]\]. Retinoids can reverse the abnormal follicular desquamation and have anti-inflammatory effects. Topical retinoids are used in the treatment of mild-to-moderate acne and are also used (off-label) to treat keratosis pilaris as well as other skin conditions. In comparison with other topical retinoids, adapalene shows lower incidence of side effects and exhibits better tolerability profile, hence is clinically above the rest in the treatment of acne vulgaris \[[@pone.0120171.ref010]--[@pone.0120171.ref012]\]. Benzoyl peroxide ([Fig. 1](#pone.0120171.g001){ref-type="fig"}) can increase skin turnover, clearing pores and reducing the bacterial count. It also has anticomedogenic and mild keratolytic effect \[[@pone.0120171.ref008],[@pone.0120171.ref009],[@pone.0120171.ref013],[@pone.0120171.ref014]\]. Hence, benzoyl peroxide is one of the most widely prescribed drugs in acne therapy. A combination of adapalene and benzoyl peroxide shows good stability and a good clinical tolerance \[[@pone.0120171.ref015]\], and has also been found to have better tolerability than BPO monotherapy in terms of cutaneous tolerability \[[@pone.0120171.ref009]\]. Thus, the first topical acne preparations combining adapalene 0.1% and benzoyl peroxide 2.5% were approved by the US Food and Drug Administration in 2008 \[[@pone.0120171.ref009],[@pone.0120171.ref016]\].

![Chemical Structure of adapalene and benzoyl peroxide.](pone.0120171.g001){#pone.0120171.g001}

There are some reported analytical methods for the determination of adapalene \[[@pone.0120171.ref015],[@pone.0120171.ref017],[@pone.0120171.ref018]\] or benzoyl peroxide alone \[[@pone.0120171.ref019]--[@pone.0120171.ref021]\] by high-performance liquid chromatography (HPLC) and capillary electrophoresis in bulk or in pharmaceutical dosage form. The purpose of this study was to develop and validate a simple HPLC method for simultaneous analysis of adapalene and benzoyl peroxide in pharmaceutical product. In order to obtain an optimal analytical condition in a short time period and minimum trails, a statistical optimization tool based on response surface methodology (RSM) with a constrained mixture design \[[@pone.0120171.ref022],[@pone.0120171.ref023]\] was used. The optimization procedure involved systematic design to minimize the number of trails, and analysis the response surfaces to realize the influence of independent factors and to obtain the optimal condition. In this present study, RSM was used to search for the appropriate mobile phase for the analysis method. Then, the analytical method was validated for specificity, linearity, accuracy, precision and robustness according to the guidelines for assay methods of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) \[[@pone.0120171.ref024]\] and applied to the analysis of a commercial product.

Materials and Methods {#sec002}
=====================

2.1. Materials {#sec003}
--------------

Adapalene with purity of 98% was purchased from Glenmark Generics Limited (Mumbai, India). Benzoyl peroxide with purity of 75% was purchased from Yuh Tzong Enterprise Ltd (Kaohsiung, Taiwan). Acetonitrile and methanol were obtained from Echo Chemical Co. (Miaoli, Taiwan). Tetrahydrofuran was obtained from J.T.Baker (Pennsylvania, U.S.A.). Purified water was prepared using Milli-Q (Millipore, MA, U.S.A.) All other chemicals and reagents used in the experiment were analytical grade. The commercial gel product (Epiduo) containing 0.1% adapalene and 2.5% benzoyl peroxide was purchased from Galderma (Levallois-Perret, France).

2.2. Standard solution preparation {#sec004}
----------------------------------

The stock solutions of adapalene and benzoyl peroxide were prepared by simultaneously dissolving 4 mg adapalene and 100 mg benzoyl peroxide in 50 ml methanol. The standard solution was prepared by diluting the stock solution with methanol to achieve a final nominal concentration of 40 μg/ml adapalene and 1 mg/ml benzoyl peroxide.

2.3. Instrumentation and chromatographic conditions {#sec005}
---------------------------------------------------

The HPLC system used consisted of a chromatographic pump (L-7100), autosampler (L-2200), and an UV detector (L-4000H) (Hitachi, Japan). The LiChrosorb C~18~ (250×4.6mm, particle size 5 μm) column and guard column 4--4 packed with LiChrosper 100 RP-18 (Merck, Darmstadt, Germany) were used. The analytical column and the guard column were operated at ambient temperature. The injection volume was 20 μL. Detection was performed at 270 nm. The flow rate was set at 1.0 ml/min.

To obtain an optimal mobile phase for the analytical method, the statistical optimization tool based on a RSM with a constrained mixture design \[[@pone.0120171.ref022],[@pone.0120171.ref023]\] was used. According to the USP 36 \[[@pone.0120171.ref018]\], the mobile phase contains acetonitrile, tetrahydrofuran, trifluoroacetic acid, and water at ratios of 21: 16: 0.01: 13 for determination of adapalene. USP 34 \[[@pone.0120171.ref021]\] reported a gradient mobile phase consists of acetonitrile and 0.1% glacial acetic aqueous solution ranged from 82/12 to 60/40 in 30 mins for benzoyl peroxide analysis. Hence, tetrahydrofuran (X~1~), acetonitrile (X~2~) and water containing 0.1% acetic acid (X~3~) was chosen as the variable factors of mobile phase in this study. The levels of X~1~, X~2~ and X~3~ were set from 10--30, 50--70 and 15--25%, respectively. Based on the constrained mixture model provided by Design-Expert software, ten model mobile phase compositions were arranged randomly. Two replicated batches of R02 vs R10 and R03 vs R09 were used to estimate the reproducibility by lack of fit. The compositions of mobile phase are listed in [Table 1](#pone.0120171.t001){ref-type="table"}. The tailing factor (TF), retention time (RT), theoretical plates (TP) and resolution of adapalene and benzyl peroxide (AB/R) were used to evaluate the availability of mobile phases.

10.1371/journal.pone.0120171.t001

###### The composition and analysis parameters of the HPLC method.

![](pone.0120171.t001){#pone.0120171.t001g}

        Code value   Adapalene   Benzoyl peroxide                                            
  ----- ------------ ----------- ------------------ ------ ------ ------ ------ ----- ------ ----
  R01   0.4          0.4         0.2                1.35   12.3   8649   1.12   3.6   8630   22
  R02   0.8          0.2         0.0                1.31   5.9    8045   1.16   2.9   7967   13
  R03   0.2          0.8         0.0                1.45   10.1   8002   1.17   3.2   8317   20
  R04   0.0          0.8         0.2                1.49   17.4   8791   1.13   3.9   8886   25
  R05   0.0          0.6         0.4                1.43   25.3   9131   1.12   4.6   9732   28
  R06   0.6          0.0         0.4                1.27   12.9   8671   1.16   3.8   8939   22
  R07   0.2          0.6         0.2                1.41   14.3   8487   1.14   3.7   8719   23
  R08   0.2          0.4         0.4                1.34   20.4   9217   1.13   4.3   9376   27
  R09   0.2          0.8         0.0                1.45   9.9    8006   1.16   3.2   8204   20
  R10   0.8          0.2         0.0                1.31   5.7    7643   1.20   2.8   7816   13

X~1~: tetrahydrofuran, X~2~: acetonitrile, X~3~: water containing 0.1% acetic acid.

TF: tailing factor, RT: retention time, TP: theoretical plates, AB/R: resolution between adapalene and benzoyl peroxide.

2.4. Method validation {#sec006}
----------------------

The HPLC method was validated for specificity, linearity, accuracy, precision and robustness according to the guidelines for assay methods of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) \[[@pone.0120171.ref024]\].

### As Specificity {#sec007}

The standard solution was used to assess the retention times. Blank chromatogram was recorded to check for interfering matrix peaks. Finally, chromatogram of real sample solution was reviewed for critical peak separations. Whenever appropriate, chromatographic resolution was calculated.

### As Linearity {#sec008}

To evaluate the linearity of the method, five standard solutions (80%\~120% of nominal concentration) were prepared. Each concentration level was analyzed in triplicate. The linearity study was performed over two days. The peak areas were plotted versus the respective concentrations, and a linear regression analysis was used to obtain the equation and correlation coefficients. The limit of detection was the lowest amount that could be detected S/N \>3.

### As Precision/Accuracy/Recovery {#sec009}

The intra-day precision and accuracy were evaluated by measuring five replicates of the samples at three concentrations levels (80, 100 and 120% of nominal concentration) on the same day, whereas the inter-day precision and accuracy were estimated using three validation batches on three consecutive days. The precision was calculated as the relative standard deviation (RSD%), and the accuracy was defined as the relative error (E%). Recovery was calculated as the ratio of the amount of drug from spiked gel to the amount of analyte added.

### As Robustness {#sec010}

The robustness was performed by modifying the experimental conditions. The chromatographic parameters including peak area, retention time, theoretical plates, and tailing factor were evaluated for different detected wavelengths (268 and 272 nm) and tetrahydrofuran concentrations (24 and 26%) and flow rate (0.9 and 1.1 mL/min).

2.5. Application of the analytical method in pharmaceutical gel {#sec011}
---------------------------------------------------------------

Accurately weighed amounts of pharmaceutical gel 2 g corresponding to 2 mg of adapalene and 50 mg of benzoyl peroxide was added into a 50 ml-volumetric flask. About 40 ml of methanol was added to this volumetric flask and sonicated in an ultrasonic bath for 15 min with intermittent shaking, diluted to volume with methanol, and mixed well. The sample solution of concentration (nominal concentration) was 40 μg/ml of adapalene and 1 mg/ml of benzoyl peroxide. Before being analyzed by HPLC, a portion of sample solution was centrifuged in tube caps at 12000 rpm for 10 min and filtered through a 0.45 μm Durapore membrane filter. A solution of blank gel containing the same excipients with commercial gel treated by the same procedure was used as a blank sample in the spectrophotometric method.

Results and Discussion {#sec012}
======================

3.1. Optimization of mobile phase {#sec013}
---------------------------------

The parameters of analysis capability of HPLC method in different mobile phase compositions are listed in [Table 1](#pone.0120171.t001){ref-type="table"}. The TF, RT and TP were 1.27--1.49, 5.9--25.3 min and 7643--9217 for adapalene, and 1.12--1.20, 2.8--4.6 min and 7816--9732 for benzoyl peroxide respectively. The AB/R ranged from 13 to 22. These results indicated that the composition of the mobile phase had significant effect on the analysis capability of this analytical method.

To determine the effect of composition of mobile phase on the analysis capability, the values of TF and RT of adapalene and benzoyl peroxide were set as responses. The TP and AB/R in all conditions were far greater than the requirement of 4000--6000 and 1.5, so does not assess in this study. These responses and three independent variables (X~1~, X~2~ and X~3~) were statistically analyzed based on the response-surface methodology using a computer program (Design-Expert software) \[[@pone.0120171.ref022],[@pone.0120171.ref025]\]. The results of multiple regression analysis for all parameters studied are summarized in [Table 2](#pone.0120171.t002){ref-type="table"}. The probability (*p*-value) of the model was less than 0.05, indicating that the fitted model could describe the relationship between the dependent and independent variables. The *p*-value for the lack of fit for all models were greater than 0.05, suggesting absence of any lack of fit of the models, and that also strengthened the reliability of the models. The values of the coefficients X~1~, X~2~ and X~3~ were related to the effect of these variables on the response. The result showed that the aqueous phase (X~3~) had more influence degree on the RT, whereas organic phases (X~1~ and X~2~) had stronger effect on TF for both analytes. The phenomena might be attribute to the reverse phase column was used for both hydrophobic analysts in this study. The increment of organic phase resulted in elution time and tailing factors of hydrophobic compounds decrease. From the response surface plots ([Fig. 2](#pone.0120171.g002){ref-type="fig"}), it was found that the appropriate analytical method with lower TF and RT for both analysts could be reach at specific mobile phase composition. Hence, the RSM was used to optimize the multiple purposes. An optimized mobile phase composition was predicted to yield RT and TF values of 12.81 min and 1.31 for adapalene, as well as 3.68 min and 1.15 for benzoyl peroxide, respectively, when level of X~1~, X~2~ and X~3~ were 25%, 50% and 25%, respectively. To validate the predictive ability of the hypothesized model for each response, a new chromatography was performed with these levels of the independent variables to yield retention time and tailing factor values of 12.09 min and 1.18 for adapalene, as well as 3.54 min and 1.15 for, benzoyl peroxide, respectively. The observed values were remarkably close to the predicted values (predicted error \< 11.1%), demonstrating that the RSM could be successfully used to optimize the proportion of mobile phase.

10.1371/journal.pone.0120171.t002

###### Optimal regression equation for each response variable.

![](pone.0120171.t002){#pone.0120171.t002g}

                    Adapalene    Benzoyl peroxide                
  ----------------- ------------ ------------------ ------------ ------------
  b~1~(X~1~)        1.31         1.54               1.18         2.71
  b~2~(X~2~)        1.54         2.53               1.15         3.33
  b~3~(X~3~)        1.11         4.22               1.08         7.11
  b~12~(X~1~X~2~)   -0.31                                        0.05
  b~13~(X~1~X~3~)   0.17                                         -2.93
  b~23~(X~2~X~3~)   0.25                                         -0.99
  F value           330.62       906.63             6.36         246.00
  *p-value*         \< 0.0001    \< 0.0001          0.0266       \< 0.0001
  *LOF(p)*          *0*.*1701*   *0*.*1724*         *0*.*7395*   *0*.*0832*
  C.V.              0.40         1.38               1.35         1.4
  R^2^              0.9976       0.9962             0.6450       0.9968
  Adjusted R^2^     0.9946       0.9951             0.5436       0.9927

TF: tailing factor, RT: retention time, LOF:Lack of Fit

![The three-dimensional contour diagrams illustrating the effect of tetrahydrofuran (X~1~), acetonitrile (X~2~) and water containing 0.1% acetic acid (X~3~) on the retention time (RT) and tailing factor (TF).](pone.0120171.g002){#pone.0120171.g002}

3.2. Method validation {#sec014}
----------------------

System suitability of the chromatographic analytical method was tested by estimating the repeatability, retention time, tailing factor and theoretical plates of six replicate injections of standard solution. The results listed in [Table 3](#pone.0120171.t003){ref-type="table"}, the TF (1.27 and 1.12), TP (8307 and 8860), and the relative standard deviation (RSD, %) (0.69% and 0.71%) for adapalene and benzoyl peroxide, respectively, were in agreement with the recommendations of FDA \[[@pone.0120171.ref026]\], indicating the analytical method could provide reliable data.

10.1371/journal.pone.0120171.t003

###### Results of system suitability.

![](pone.0120171.t003){#pone.0120171.t003g}

  Parameters           Value (Mean ±RSD %)   
  -------------------- --------------------- -------------
  Peak area            913465±0.69           346363±0.71
  Retention time       13.4±0.35             3.82±0.12
  Tailing factors      1.27±0.62             1.12±0.23
  Theoretical plates   8307±0.24             8860±0.89

RSD %: Relative standard deviation

In term of specificity, placebo interference was carried out to investigate the specificity of the analytes (adapalene and benzoyl peroxide) in pharmaceutical preparation. The chromatograms of the blank solution, standard solution (nominal concentration), blank sample solution, and real sample solution were used to justify the specificity of the analytical method. As shown in [Fig. 3](#pone.0120171.g003){ref-type="fig"}, there was no interference from the other compounds, which, therefore, confirms the specificity of the method. The running time of this analytical method was 15 min, which was shorter than USP reported \[[@pone.0120171.ref018],[@pone.0120171.ref021]\].

![Chromatograms obtained for (A) real sample, (B) standard solution (nominal concentration), (C) blank sample, and (D) blank solution.](pone.0120171.g003){#pone.0120171.g003}

The linearity of the analytical method was determined by linear regression analysis obtaining a calibration curve by plotting the peak area versus a series of concentrations including 80%, 90%, 100%, 110% and 120% of nominal concentration of standard solution. The calibration curve obtained by analyzing adapalene was y = 32922+23913x with a correlation coefficient (r) of 0.9992, whereas the equation of a curve obtained by assaying benzoyl peroxide was y = 229017+3155x (r = 0.9996). The limits of detection of adapalene and benzoyl peroxide were 4 and 7 μg/ml, respectively. Results for accuracy, precision and recovery are presented in [Table 4](#pone.0120171.t004){ref-type="table"}. All values of accuracy and precision were within acceptable limits with E% and RSD no greater than 15% \[[@pone.0120171.ref026]\]. The recovery ratios were greater than 97.97%. [Table 5](#pone.0120171.t005){ref-type="table"} shows the results obtained from study of robustness determined by performing small changes or variations in the method's parameters such as detecting wavelength, flow rate and tetrahydrofuran concentration in mobile phase. None of the alterations caused a significant effect on the determination of both analytes, indicating the robustness of the developed method.

10.1371/journal.pone.0120171.t004

###### Accuracy, precision and recovery of the analytes.
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  Theoretical Concentration (μg/ml)   Accuracy   Within-Day Variability   Between-Day Variability   Recovery               
  ----------------------------------- ---------- ------------------------ ------------------------- --------------- ------ -------------
  Adapalene                                                                                                                
  32                                  -0.83      31.99±0.24               0.74                      31.73±0.10      0.31   100.90±1.28
  40                                  -1.63      39.59±0.36               0.90                      39.35±0.46      1.17   97.97±0.32
  48                                  -1.50      47.85±0.86               1.80                      47.28±0.10      0.22   97.98±0.78
  Benzoyl peroxide                                                                                                         
  800                                 -0.93      795.65± 6.52             0.82                      792.57± 3.72    0.47   99.02±0.01
  1000                                -0.72      993.52± 9.15             0.92                      992.83±13.93    1.40   99.03±0.00
  1200                                -1.38      1192.59±18.53            1.55                      1183.42± 3.22   0.27   99.02±0.01

E%: relative error of measurement, RSD (%): relative standard deviation.

10.1371/journal.pone.0120171.t005

###### Robustness results of method.
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                         Adapalene   Benzoyl peroxide                                         
  ---------------------- ----------- ------------------ ------ ------ --------- ----- ------- ------
  Normal                 906827      13.2               1.28   8562   3394717   3.8   1.134   8855
  Tetrahydrofuran 26%    894564      11.9               1.28   8408   3318054   3.7   1.123   8818
  Tetrahydrofuran 24%    888586      15.0               1.27   8681   3341686   4.0   1.111   9158
  Detector 272 nm        834416      13.5               1.28   8818   3245174   3.9   1.132   9566
  Detector 268 nm        901013      13.4               1.29   8567   3307417   3.8   1.131   9050
  Flow rate 0.9 mL/mim   871002      14.1               1.30   8351   3251436   4.2   1.141   8721
  Flow rate 1.1 mL/mim   858859      13.1               1.27   8461   3325463   3.7   1.132   8926

Area: peak area, RT: retention time, TF: tailing factors, TP: theoretical plates.

3.3. Application of the analytical method to pharmaceutical gel {#sec015}
---------------------------------------------------------------

In order to test the method on commercial product, the absolute recoveries of adapalene and benzoyl peroxide from commercial gel (Epiduo) containing 0.1% adapalene and 2.5% benzoyl peroxide was determined. The recoveries of adapalene and benzoyl peroxide were 93.11±0.78% and 95.17±1.02%, respectively, that fall within limits of the USP monograph.

Conclusion {#sec016}
==========

The RSM was successfully to optimize the composition of mobile phase. The selective, precise, accurate, linear and robust of this developed analytical method was met ICH guideline indicated its stability.
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